Purpose: Sensitivity of tumor cells towards chemotherapy mainly determines the prognosis of patients suffering from acute lymphoblastic leukemia (ALL); nevertheless, underlying mechanisms regulating chemo-sensitivity remain poorly understood. Here, we aimed at characterizing the role of Caspase-8 for chemosensitivity of B-and T-ALL cells.
Introduction
Downregulation of pro-apoptotic signaling proteins represents an important mechanism, how tumor cells evade anti-cancer treatment. As an example, Caspase-8 is frequently downregulated in tumor cells of different origins, mostly due to epigenetic gene silencing by promoter hypermethylation [1] [2] [3] . De-methylating agents like azacythidine induce re-expression of Caspase-8 and sensitize for Caspase-8 dependent apoptosis 1, 2 . Loss or dysfunction of Caspase-8 result in increased cellular transformation, enhanced tumor progression, poor response to chemotherapy and impaired prognosis of patients of different cancer entities [4] [5] [6] [7] [8] .
Several attempts were undertaken to upregulate the expression of Caspase-8 in tumor cells. The Caspase-8 promoter contains binding sites for NFκB, SP-1, IRF-1 and p53, and efficient upregulation of Caspase-8 was obtained upon stimulation of the STAT-1/IRF-1 pathway 2 . For epigenetically downregulated Caspase-8, azacythidine and IFN-γ were effective 9, 10 . In addition to azacythidine, we have recently shown that epigenetically downregulated Caspase-8 can be upregulated by routinely used cytotoxic drugs like methotrexate (MTX) via the transcription factor p53 11 .
Caspase-8 is mainly known for its important role within the extrinsic apoptosis pathway, where it signals from proximal death receptor activation to activation of caspases or mitochondria 12, 13 . In contrast, cytotoxic drugs mainly signal via the intrinsic apoptosis signaling pathway where activated mitochondria release apoptogenic factors like Cytochrome c for cleavage of downstream effector caspases 14, 15 . The role of Caspase-8 for intrinsic apoptosis signaling has been controversially discussed 1, [16] [17] [18] [19] : Recent data provided evidence for an downstream amplifier function of Caspase-8 during drug-induced cell death in some, but not all tumor types 20, 21 . For acute lymphoblastic leukemia (ALL), the role of Caspase-8 remains poorly defined. Interestingly, a recent paper showed that in patients with childhood ALL, high mRNA levels of Caspase-8 were predictive for a good initial response to polychemotherapy 8 .
We aimed to characterize the functional relevance of Caspase-8 for cytotoxic druginduced apoptosis in patient-derived childhood ALL cells. Using molecular studies,
we found a surprisingly important function of Caspase-8 for chemo-sensitivity of ALL cells.
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Materials and Methods

Materials
TRAIL from Pepro (Peprotech, Hamburg, Germany) without his-tag was used exclusively for all experiments. Anti-apo1, Fas receptor blocking antibody, DR4 and DR5 Fc fragments and zIETD were obtained by Alexis Corp. (Grünberg, Germany), methotrexate from Calbiochem (San Diego, CA), 4-hydroperoxy-cyclophosphamide from Baxter oncology GmbH (Frankfurt, Germany). All further reagents from Sigma (Deisenhofen, Germany). For Western Blot, the following antibodies were used: anti-GAPDH from Thermo Fisher (Waltham, MA), anti-p53 and anti-Lamin A/C from Santa Cruz (Santa Cruz, CA) and anti-Caspase-8 from Alexis Corp.
Cell lines, primary samples and amplification in NOD/SCID mice, cell death assays
All parental cell lines were obtained from DSMZ (Braunschweig, Germany), CEM-TR and J-TR cells had been described previously 11, 16 . After thawing, parental cells were amplified and numerous aliquots were frozen within 1 month after thawing of original cells. Each frozen aliquot was than re-thawn and used for a maximum of three months after thawing. Derivative cells stably transfected with shRNA against Caspase-8 or p53 have been published before and cells were maintained as described there 11, 16 . For all cell line experiments, cells were seeded as described before and incubated with cytotoxic drugs for 48 hours 11 . For combined stimulation, cells were incubated with MTX for 48 hours followed by the second stimulant for additional 48 hours. Cell death was measured by forwardside scatter analysis using FACscan (Becton Dickinson, Heidelberg, Germany). For biochemical inhibition of Caspase-8 or death receptor blockade, cell lines were pretreated for 6 hours before stimulation.
Primary leukemia blasts were investigated from n=29 children treated for acute leukemia at the Ludwig Maximilians University's children's hospital and the children's hospital of the TU Munich during 2005 and 2008. All experiments were approved by the local ethics boards according to the declaration of Helsinki. Samples were obtained, isolated and seeded as described 11 . Cells were stimulated simultaneously with methotrexate (30 µM) and TRAIL (1µg/ml) or cytotoxic drugs at peak plasma concentration as described previously 22 . TRAIL resistance was defined as specific ALL 6 cell death by TRAIL < 10 %. For molecular studies, primary cells were xenografted in NOD/SCID mice and amplified before molecular modulation.
Western Blot analysis
Western Blot analysis of total cellular protein was performed for all cell line experiments as described 16 . For investigation of primary samples, Iceman´s lysis buffer (Tris HCl 10 mM pH 7,5, NaCl 50 mM, Triton X-100 0,5 %, desoxycholic acid 0,5 %, sodium duodecyl sulfate 0,5 %) was used. For quantification of Caspase-8 expression in primary samples, AIDA Image Analyzer was applied.
Transfection experiments
In addition to formerly described stably transfected cell lines, parental CEM and JURKAT cells were stably transfected with previously specified vectors expressing shRNA against Caspase-8 or a mock sequence using the Amaxa Cell Line
Nucleofactor kit V (Lonza, Basel, Switzerland) according to the manufacturers' 
Statistical analysis
Normalized isobolograms were generated using CompuSyn software. 
Results
Caspase-8 plays a pivotal role for apoptosis induction via the extrinsic apoptosis signaling cascade, while its role for intrinsic apoptosis signaling induced by cytotoxic drugs appears tumor type specific 20, 21 . Here, we characterized the role of Caspase-8 for cell death induction by cytotoxic drugs in B-and T-ALL cells.
Cytotoxic drug-induced cell death depends on Caspase-8
The T-cell ALL cell lines CEM and JURKAT showed abundant expression of Figure 1C and data not shown) 22, 24 .
Thus, Caspase-8 represents an important intracellular signaling mediator for a high number of cytotoxic drugs used in routine anti-leukemia treatment.
Caspase-8 is downregulated in a subset of primary ALL cells
As we found an important role of Caspase-8 for drug induced cell death in ALL cell lines, we next investigated the Caspase-8 expression levels in primary ALL cells. In many solid tumor entities like neuroectodermal tumors, downregulation of Caspase-8 is a frequent event in patients´ tumors associated with drug resistance and poor prognosis 2, 5, 8 . In line, high expression levels of Caspase-8 mRNA were prognostically significant for favorable response to initial chemotherapy in childhood ALL 7, 8 .
To further clarify the role of Caspase-8 for efficient apoptosis induction, we 
Cytotoxic drugs induce cell death independently from death receptor signaling
During cell death signaling, Caspase-8 can be activated by two different mechanisms: Upon extrinsic apoptosis signaling, Caspase-8 becomes activated in the proximal cell death signaling pathway at the death receptors. Within the intrinsic apoptosis signaling pathway, Caspase-8 is activated downstream of mitochondria by executioner Caspases to fulfill an amplifier function 11, 19 . During drug-induced cell death, the activation of the death receptor system has been controversially discussed [25] [26] [27] .
To discriminate, whether Caspase-8 becomes activated by the extrinsic or the intrinsic apoptosis signaling pathway upon stimulation by cytotoxic drugs in ALL cells, 
MTX upregulates epigenetically downregulated Caspase-8
So far, we have shown that Caspase-8 plays an important role for cell death induction by a number of cytotoxic drugs in ALL cells (Figure 1 and 2) . Surprisingly, a relevant subset of primary ALL cells expressed only low amounts of Caspase-8 protein followed by reduced in vitro sensitivity for cytotoxic drugs ( Figure 2 ). As patients carrying these tumor cells might be of high risk for poor response to initial polychemotherapy 7, 8 , they might benefit from strategies restoring the expression of Since decades, MTX is successfully used in combination with nearly all drugs used in polychemotherapy protocols of ALL [29] [30] [31] . Our data show that a possible explanation for the favorable effects of some of these drug combinations might rely on regulation of Caspase-8. In addition, MTX sensitized for apoptosis induction by drugs signaling Caspase-8 independent cell death. MTX sensitized ALL-cells for cytarabine and etopside by a Caspase-8 and p53 independent mechanism (data not shown). To our surprise, we were not able to identify a specific group of p53 regulators able to restore Caspase-8 within our experimental setting, but MTX was the only drug besides the formerly described 5-FU 11,32 .
More recently, it has become increasingly clear that anti-tumor therapy has to target epigenetic tumor alterations 33, 34 . Caspase-8 is one of the frequently downregulated proteins due to epigenetic silencing 1, 3, 10 . We can show here that MTX that is part of anti-leukemia protocols for decades, is able to upregulate epigenetically On a more general level, our work encourages the future search for targeted drug combinations which are based on the molecular understanding of the underlying signaling mechanism. Cytotoxic drugs that regulate Caspase-8 should be combined with drugs that depend on the expression of Caspase-8. These drug combinations inherit the potential of higher anti-tumor efficiency compared to empirically determined drug combinations. This approach is in line with current concepts of targeted therapies and the re-evaluation of drug combinations [35] [36] [37] . The current search of targeted therapeutics should be accompanied by a search for targeted drug combinations.
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on Figure 1A and Supplementary Figure 1D .
Doxo and VCR were applied at 30ng/ml. Figure 1A were stimulated with Doxo for 48 hours as indicated.
C) CEM cells from
Cell death was measured using forwardside scatter analysis. Data are presented as mean ± SEM of at least three independent experiments. * p<0,05, ANOVA, comparing parental and mock cells to shCasp8 and CEM-TR cells. NS = not significant. Parental CEM cells were pretreated with Fas blocking antibody (1 µg/ml) and DR4 and DR5 Fc fragments (1 µg/ml each) (R-block) for 6 hours followed by stimulation with cytotoxic drugs as in Figure 1A .
Apoptosis measurement, presentation and statistical analysis were performed as in Figure 1 . Cell death measurement and Western Blot were performed as in Figure 1 and presentation of data as in Figure 4 if not stated differently.
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